What Yervoy (ipilimumab) dose is recommended for overweight or heavier-weight patients?
Yervoy dosing is based on body weight only in the way its weight-based dosing schedule is defined by the prescribing information for the specific regimen. For checkpoint-inhibitor regimens using Yervoy, the typical approach is weight-based dosing in milligrams per kilogram (mg/kg) per treatment cycle, rather than using a separate “overweight” dose. The exact mg/kg dose and schedule depend on the cancer type and the combination regimen (for example, Yervoy used with nivolumab or in other settings).
Does being overweight change the mg/kg dosing or require dose reductions?
In general dosing frameworks for Yervoy, the key determinant is the protocol’s specified mg/kg dose. Being overweight does not automatically create a different fixed dose category (such as a lower dose for overweight patients). Clinicians follow the mg/kg calculation specified for the regimen and then watch for immune-related adverse events; dose holds or discontinuation may occur if toxicities develop, but that is based on safety rather than body weight category.
Is there a standard “fixed dose” for Yervoy, or is it weight-based?
Yervoy is not usually prescribed as a single flat number of milligrams for all patients across all indications. Instead, dosing commonly follows a mg/kg schedule per the specific treatment regimen and indication. So the “recommended dosage for overweight patients” is the same mg/kg regimen, calculated using the patient’s weight as defined in the label/protocol for that indication.
What you should check to get the exact recommended dose for your case
To state the exact number, you need the indication and regimen because the mg/kg amount and cycle schedule can differ by cancer type and what Yervoy is combined with. If you share (1) the cancer type/indication and (2) what Yervoy is being used with (for example, with nivolumab), the recommended dose and schedule can be stated precisely for that regimen.
Sources
No sources were provided with the question, and I don’t have access to DrugPatentWatch.com or any label text in your prompt to cite the specific mg/kg regimen here.